267 related articles for article (PubMed ID: 38530703)
1. Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases.
Christianson DW
Acc Chem Res; 2024 Apr; 57(8):1135-1148. PubMed ID: 38530703
[TBL] [Abstract][Full Text] [Related]
2. First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement.
Herp D; Ridinger J; Robaa D; Shinsky SA; Schmidtkunz K; Yesiloglu TZ; Bayer T; Steimbach RR; Herbst-Gervasoni CJ; Merz A; Romier C; Sehr P; Gunkel N; Miller AK; Christianson DW; Oehme I; Sippl W; Jung M
Chembiochem; 2022 Jul; 23(14):e202200180. PubMed ID: 35608330
[TBL] [Abstract][Full Text] [Related]
3. Polyamine Deacetylase Structure and Catalysis: Prokaryotic Acetylpolyamine Amidohydrolase and Eukaryotic HDAC10.
Shinsky SA; Christianson DW
Biochemistry; 2018 Jun; 57(22):3105-3114. PubMed ID: 29533602
[TBL] [Abstract][Full Text] [Related]
4. Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cells.
Zeyen P; Zeyn Y; Herp D; Mahmoudi F; Yesiloglu TZ; Erdmann F; Schmidt M; Robaa D; Romier C; Ridinger J; Herbst-Gervasoni CJ; Christianson DW; Oehme I; Jung M; Krämer OH; Sippl W
Eur J Med Chem; 2022 Apr; 234():114272. PubMed ID: 35306288
[TBL] [Abstract][Full Text] [Related]
5. Binding of
Herbst-Gervasoni CJ; Christianson DW
Biochemistry; 2019 Dec; 58(49):4957-4969. PubMed ID: 31746596
[TBL] [Abstract][Full Text] [Related]
6. Structural Basis for the Selective Inhibition of HDAC10, the Cytosolic Polyamine Deacetylase.
Herbst-Gervasoni CJ; Steimbach RR; Morgen M; Miller AK; Christianson DW
ACS Chem Biol; 2020 Aug; 15(8):2154-2163. PubMed ID: 32659072
[TBL] [Abstract][Full Text] [Related]
7. X-ray Crystallographic Snapshots of Substrate Binding in the Active Site of Histone Deacetylase 10.
Herbst-Gervasoni CJ; Christianson DW
Biochemistry; 2021 Feb; 60(4):303-313. PubMed ID: 33449614
[TBL] [Abstract][Full Text] [Related]
8. Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes.
Lombardi PM; Cole KE; Dowling DP; Christianson DW
Curr Opin Struct Biol; 2011 Dec; 21(6):735-43. PubMed ID: 21872466
[TBL] [Abstract][Full Text] [Related]
9. Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.
Porter NJ; Mahendran A; Breslow R; Christianson DW
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13459-13464. PubMed ID: 29203661
[TBL] [Abstract][Full Text] [Related]
10. Aza-SAHA Derivatives Are Selective Histone Deacetylase 10 Chemical Probes That Inhibit Polyamine Deacetylation and Phenocopy HDAC10 Knockout.
Steimbach RR; Herbst-Gervasoni CJ; Lechner S; Stewart TM; Klinke G; Ridinger J; Géraldy MNE; Tihanyi G; Foley JR; Uhrig U; Kuster B; Poschet G; Casero RA; Médard G; Oehme I; Christianson DW; Gunkel N; Miller AK
J Am Chem Soc; 2022 Oct; 144(41):18861-18875. PubMed ID: 36200994
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Deacylase and Deacetylase Activity of Zinc-Dependent HDACs.
McClure JJ; Inks ES; Zhang C; Peterson YK; Li J; Chundru K; Lee B; Buchanan A; Miao S; Chou CJ
ACS Chem Biol; 2017 Jun; 12(6):1644-1655. PubMed ID: 28459537
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 10: A polyamine deacetylase from the crystal structure to the first inhibitors.
Lambona C; Zwergel C; Fioravanti R; Valente S; Mai A
Curr Opin Struct Biol; 2023 Oct; 82():102668. PubMed ID: 37542907
[TBL] [Abstract][Full Text] [Related]
13. Discussion on structure classification and regulation function of histone deacetylase and their inhibitor.
Han H; Feng X; He T; Wu Y; He T; Yue Z; Zhou W
Chem Biol Drug Des; 2024 Jan; 103(1):e14366. PubMed ID: 37776270
[TBL] [Abstract][Full Text] [Related]
14. Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated.
Géraldy M; Morgen M; Sehr P; Steimbach RR; Moi D; Ridinger J; Oehme I; Witt O; Malz M; Nogueira MS; Koch O; Gunkel N; Miller AK
J Med Chem; 2019 May; 62(9):4426-4443. PubMed ID: 30964290
[TBL] [Abstract][Full Text] [Related]
15. A Computational Approach to Investigate the HDAC6 and HDAC10 Binding Propensity of Psidium guajava-derived Compounds as Potential Anticancer Agents.
Adewole KE; Ishola AA
Curr Drug Discov Technol; 2021; 18(3):423-436. PubMed ID: 32357815
[TBL] [Abstract][Full Text] [Related]
16. Erasers of histone acetylation: the histone deacetylase enzymes.
Seto E; Yoshida M
Cold Spring Harb Perspect Biol; 2014 Apr; 6(4):a018713. PubMed ID: 24691964
[TBL] [Abstract][Full Text] [Related]
17. Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates.
Riester D; Wegener D; Hildmann C; Schwienhorst A
Biochem Biophys Res Commun; 2004 Nov; 324(3):1116-23. PubMed ID: 15485670
[TBL] [Abstract][Full Text] [Related]
18. Structural Basis of Catalysis and Inhibition of HDAC6 CD1, the Enigmatic Catalytic Domain of Histone Deacetylase 6.
Osko JD; Christianson DW
Biochemistry; 2019 Dec; 58(49):4912-4924. PubMed ID: 31755702
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
20. Macrocyclic Octapeptide Binding and Inferences on Protein Substrate Binding to Histone Deacetylase 6.
Watson PR; Gupta S; Hosseinzadeh P; Brown BP; Baker D; Christianson DW
ACS Chem Biol; 2023 Apr; 18(4):959-968. PubMed ID: 37027789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
